Cryo-Cell International Inc. (NYSEAMERICAN:CCEL – Get Free Report) passed below its two hundred day moving average during trading on Thursday. The stock has a two hundred day moving average of $3.73 and traded as low as $3.65. Cryo-Cell International shares last traded at $3.65, with a volume of 16,731 shares.
Cryo-Cell International Trading Up 21.1%
The stock’s fifty day moving average is $4.11 and its two-hundred day moving average is $3.74. The company has a market capitalization of $35.63 million, a PE ratio of -19.22 and a beta of 0.50.
Cryo-Cell International (NYSEAMERICAN:CCEL – Get Free Report) last posted its quarterly earnings results on Friday, October 9th. The company reported $0.16 earnings per share for the quarter. The company had revenue of $7.82 million for the quarter.
Institutional Inflows and Outflows
An institutional investor recently raised its position in Cryo-Cell International stock. Susquehanna International Group LLP raised its position in shares of Cryo-Cell International Inc. (NYSEAMERICAN:CCEL – Free Report) by 40.4% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 14,064 shares of the company’s stock after purchasing an additional 4,046 shares during the period. Susquehanna International Group LLP owned 0.17% of Cryo-Cell International worth $45,000 as of its most recent filing with the Securities and Exchange Commission. 10.44% of the stock is owned by institutional investors.
About Cryo-Cell International
Cryo-Cell International, Inc is a biotechnology company that provides private stem cell banking and related biorepository services. The company collects, processes and cryogenically stores biological materials obtained primarily from umbilical cord blood and cord tissue, which may be preserved for potential future medical use by the donor or family members.
Its services generally include the coordination of collection kits and medical collection procedures, laboratory processing, testing and long-term storage.
Further Reading
- Five stocks we like better than Cryo-Cell International
- Rocket Lab’s Neutron Delay Leaves Wall Street Bullish But Raises the Stakes for 2027
- ManpowerGroup Stock Sinks on Q3 Results, But Fundamentals Stay Solid
- Does the AI Selloff Put Alphabet’s Breakout in Doubt?
- Bank Earnings Are Mixed—These 2 ETFs Offer Very Different Paths to a Recovery
Receive News & Ratings for Cryo-Cell International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cryo-Cell International and related companies with MarketBeat.com's FREE daily email newsletter.
